KRAS and inflammatory bowel disease: As expected, somatic mutations in APC and KRAS were less frequent in IBD-CRC; a significant enrichment of somatic mutations at noncoding 5′UTR of TP53 in IBD-CRC, resulting in low TP53 expression, was found.